Security Fears Put Scientists Under Scrutiny

Michael Goldberg expected to hear from the FBI because he knew the agency wanted "The List." So the phone call from federal investigators to the American Society of Microbiology in Washington, DC, requesting the names and addresses of 43,000 members came as no surprise. Goldberg, the society's executive director, received a letter citing the names of two agents who would come to the ASM office. The letter says it "reaffirms ... that all membership information disclosed by ASM will be used for of

Written byWillie Schatz
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The organization happily complied with the FBI. But the official scrutiny fuels a growing uneasiness among some US life scientists. Once touted as the leaders of the country's next economic miracle—a burgeoning biotechnology sector—they increasingly feel themselves the targets of paranoia and misunderstanding.

The controversy over cloning and stem cell research had already created a rift between biologists and policymakers. The investigation into anthrax-tainted mail that prompted the FBI's inquiry about the ASM membership has only heightened some biologists' worries that the federal government now views them with distrust.

"Science has gone from a very mildly regulated industry to one of the most regulated," says Sharon Krag, associate dean for graduate education and research at Johns Hopkins University's Bloomberg School of Public Health. "This was an issue before Sept. 11 and anthrax. But those events have made things more acute."

Krag cheerfully acknowledges that the public has a right to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies